Patents Assigned to Genzyme Therapeutic Products Limited Partnership
  • Treatment of Pompe's Disease
    Publication number: 20140037611
    Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
    Type: Application
    Filed: May 3, 2013
    Publication date: February 6, 2014
    Applicant: Genzyme Therapeutic Products Limited Partnership
    Inventors: Johannes B.M.M. van Bree, Edna H.G. Venneker, David P. Meeker
  • Treatment of Pompe's Disease
    Publication number: 20130039901
    Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
    Type: Application
    Filed: December 21, 2011
    Publication date: February 14, 2013
    Applicant: Genzyme Therapeutic Products Limited Partnership
    Inventors: Johannes B.M.M. van Bree, Edna H.G. Venneker, David P. Meeker
  • Treatment of Pompe's Disease
    Publication number: 20100092449
    Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
    Type: Application
    Filed: December 9, 2009
    Publication date: April 15, 2010
    Applicant: Genzyme Therapeutic Products Limited Partnership
    Inventors: Johannes B.M.M van Bree, Edna H.G. Venneker, David P. Meeker
  • Treatment of Pompe's disease
    Patent number: 7655226
    Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
    Type: Grant
    Filed: January 30, 2008
    Date of Patent: February 2, 2010
    Assignee: Genzyme Therapeutic Products Limited Partnership
    Inventors: Johannes B. M. M. Van Bree, Edna H. G. Venneker, David P. Meeker
  • Treatment of Pompe's disease
    Patent number: 7351410
    Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: April 1, 2008
    Assignee: Genzyme Therapeutic Products Limited Partnership
    Inventors: Johannes B. M. M. van Bree, Edna H. G. Venneker, David P. Meeker